Search Results 671-680 of 17070 for Ozone therapy

  1. Doctors & Departments - Mayo Clinic

    This designation recognizes an institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.

  2. Anxiety Disorders Clinical Trials - Mayo Clinic Research

    First, can exposure therapy for childhood anxiety begin earlier in the course of treatment than current treatment manuals suggest? Second, is treating childhood ...

  3. Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN) - Mayo Clinic

    About this study. The investigators goal is to evaluate the role of XOLAIR® in treatment of Acute Tubulointerstitial Nephritis (AIN) with the goal of ...

  4. Cryotherapy for prostate cancer - Care at Mayo Clinic

    Advanced diagnosis and treatment · The latest imaging tests for treatment planning. Mayo Clinic doctors use the latest imaging techniques to plan your ...

  5. Crohn's Disease Clinical Trials - Mayo Clinic Research

    This study (UNITI-2) will compare the effects (both positive and negative) of an initial treatment with ustekinumab to a placebo over 8 weeks in patients with ...

  6. Asthma - Symptoms and causes - Mayo Clinic

    Asthma treatment: 3 steps to better asthma control · Asthma: Steps in testing and diagnosis · Dry powder disk inhaler · Dry powder tube inhaler · Ozone air ...

  7. Mayo Clinic Radio: Pain management / Well Living Lab / childhood obesity / proton beam therapy

    To find better ways to manage chronic pain, clinical trials at Mayo Clinic are testing complementary therapies, such as acupuncture, massage and yoga, as ...

  8. Sharing Mayo Clinic: Proton Beam Therapy at the Right Time for Jackson

    For two weeks, 14-year-old Jackson Fisher was plagued by headaches, double-vision, nausea and weight loss. His parents, Michelle and Patrick Fisher, ...

  9. Pulmonary Medicine Clinical Trials - Medical Professionals

    Treatment for FSGS is considered unsuccessful if the patient is unresponsive to standard therapy (e.g., at least 8 weeks of corticosteroids) and fails to ...

  10. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in participants with moderately and ...